What is the address of ENDOCURE?

The registered office of ENDOCURE is located at Dageraadlaan 32, 1652 Beersel.

Is ENDOCURE still active?

Yes. According to the CBE (17 September 2026) ENDOCURE is active, legal situation “Normale toestand”, started on 7 June 2022.

Is ENDOCURE registered on Peppol?

Yes, ENDOCURE is registered on the Peppol network with ID 0208:0786853211.

What is the enterprise number of ENDOCURE?

The enterprise number of ENDOCURE is BE0786853211.

When was ENDOCURE founded?

ENDOCURE was founded on 7 June 2022.

Who are the directors of ENDOCURE?

According to the 2025 annual accounts, the directors of ENDOCURE are: YOUSSEF MOURABIT.

Is ENDOCURE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 June 2022; 3 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did ENDOCURE make in 2025?

ENDOCURE posted a profit after taxes of € 125,992 in financial year 2025.

What is the revenue of ENDOCURE?

As a small company, ENDOCURE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 182,215.

ENDOCURE (Private Limited) - Beersel - BE0786853211

Dossier ENDOCURE, printed on 17 September 2026 from databakkes.be/en/0786853211/endocure. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

ENDOCURE from Beersel, company number BE0786853211, closed financial year 2025 with a result of € 125,992 after tax. For that financial year ENDOCURE recorded a gross margin of € 182,215 and equity of € 239,878. Compared with financial year 2024, the result moved from € 21,377 to € 125,992. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 239,878

▲ 111% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 125,992

▲ € 104,614 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 145,516

▲ 70% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 235,878.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 2,798

▼ 77% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,152

▲ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 38,519

▲ 192% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 160,516 Gross margin 2023: € 160,516 First fiscal year in the series	€ 56,993 Gross margin 2024: € 56,993 ▼ 64% vs 2023 (€ 160,516) Unfavourable step	€ 182,215 Gross margin 2025: € 182,215 ▲ 220% vs 2024 (€ 56,993) Favourable step	▲ 220%
Profit after taxes	€ 88,761 Profit after taxes 2023: € 88,761 First fiscal year in the series	€ 21,377 Profit after taxes 2024: € 21,377 ▼ 76% vs 2023 (€ 88,761) Unfavourable step	€ 125,992 Profit after taxes 2025: € 125,992 ▲ € 104,614 vs 2024 (€ 21,377) Favourable step	▲ € 104,614
Equity	€ 92,761 Equity 2023: € 92,761 First fiscal year in the series	€ 113,950 Equity 2024: € 113,950 ▲ 23% vs 2023 (€ 92,761) Favourable step	€ 239,878 Equity 2025: € 239,878 ▲ 111% vs 2024 (€ 113,950) Favourable step	▲ 111%
Total debts	€ 89,960 Total debts 2023: € 89,960 First fiscal year in the series	€ 25,312 Total debts 2024: € 25,312 ▼ 72% vs 2023 (€ 89,960) Favourable step	€ 42,671 Total debts 2025: € 42,671 ▲ 69% vs 2024 (€ 25,312) Unfavourable step	▲ 69%
Cash	€ 145,628 Cash 2023: € 145,628 First fiscal year in the series	€ 85,718 Cash 2024: € 85,718 ▼ 41% vs 2023 (€ 145,628) Unfavourable step	€ 145,516 Cash 2025: € 145,516 ▲ 70% vs 2024 (€ 85,718) Favourable step	▲ 70%
Retained profit	€ 88,761 Retained profit 2023: € 88,761 First fiscal year in the series	€ 109,950 Retained profit 2024: € 109,950 ▲ 24% vs 2023 (€ 88,761) Favourable step	€ 235,878 Retained profit 2025: € 235,878 ▲ 115% vs 2024 (€ 109,950) Favourable step	▲ 115%
Bank debt	€ 24,758 Bank debt 2023: € 24,758 First fiscal year in the series	€ 8,357 Bank debt 2024: € 8,357 ▼ 66% vs 2023 (€ 24,758) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 8,357) Favourable step	▼ 100%
Balance sheet total	€ 182,721 Balance sheet total 2023: € 182,721 First fiscal year in the series	€ 139,262 Balance sheet total 2024: € 139,262 ▼ 24% vs 2023 (€ 182,721) Unchanged	€ 282,549 Balance sheet total 2025: € 282,549 ▲ 103% vs 2024 (€ 139,262) Unchanged	▲ 103%

Key figures of ENDOCURE, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ENDOCURE?

What happened at ENDOCURE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 125,992 (▲ € 104,614 vs 2024). filed late Source: NBB ↗
2022 YOUSSEF MOURABIT became a director. NBB
Jun 7, 2022 Start of the company according to the CBE. KBO

In short

From € 88,761 profit in 2023 to € 125,992 profit in 2025.

Paid € 83,440 in corporate taxes since 2023.

Best year ever: 2025, with € 125,992 profit.

Original PDFs at the National Bank ↗

A new publication or filing at ENDOCURE? We notify you, reason included.

Follow ENDOCURE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

YOUSSEF MOURABIT

ENDOCURE

Behind ENDOCURE is YOUSSEF MOURABIT.

See the full network in the app

Directors

According to the 2025 annual accounts

YOUSSEF MOURABIT

Administrator-manager

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Dageraadlaan 32

1652 Beersel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0786.853.211
VAT number: BE 0786.853.211
Registered office: Dageraadlaan 32, 1652 Beersel
Names & denominations: ENDOCURE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 June 2022
Peppol: Active · Active since 1 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗